Vanta Bioscience Ltd

Thu 10/09/2026,16:1:0 | BSE : VANTABIO

₹20.580.98 (5.00%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 18.62

Previous Close

₹ 19.60

Volume

5250

Mkt Cap ( ₹ Cr)

₹ 14.64

High

₹ 20.58

Low

₹ 18.62

52 Week High

₹ 29.00

52 Week Low

₹ 14.71

Book Value Per Share

₹ 29.77

Dividend Yield

₹ 0.00

Face Value

₹₹10.00

What's Your Call?

Collective community sentiment on Vanta Bioscience Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vanta Bioscience Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vanta Bioscience - Board Meeting Outcome for Outcome Of Board Meeting Held On 05.09.2026 - 10Th Annual General Meeting ('AGM'

    5 Sep 2026, 4:57PM Outcome of Board Meeting held on 05.09.2026 - 10th AGM to be held on 30.09.2026

Key fundamentals

Evaluate the intrinsic value of Vanta Bioscience Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 59.3314 47.6046 45.1729 45.5003 44.7576
Liabilities 59.3314 47.6046 45.1729 45.5003 44.7576
Equity 7.112 6.312 6.312 6.312 6.312
Gross Profit 1.0308 -1.6555 3.6522 -0.4755 3.4018
Net Profit 0.1198 -2.6594 0.051 -4.2354 0.0785
Cash From Operating Activities -5.2193 1.3614 4.5421 0.6447 6.7025
NPM(%) 6.59 -235.88 0.59 -81.9 0.83
Revenue 1.8164 1.1274 8.5579 5.1709 9.3498
Expenses 0.7856 2.783 4.9056 5.6465 5.948
ROE(%) 0.56 -12.55 0.24 -20 0.37

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Vanta Bioscience Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 871.35 2.55 22.22 11.75 -26.19 0.57
Lotus Eye Hospital and Institute Ltd 116.60 0.30 1646.29 42.80 0.39 0.00
Bharat Immunological and Biologicals Corporation Ltd 13.40 -4.08 0.00 88.86 -39.50 0.00
Astec Lifesciences Ltd 756.25 -4.74 0.00 45.86 -363.14 0.00

Company Info

The Company was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name "Vanta Bioscience Private Limited`. The Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13, 2017 and consequently, the name of the Company was changed to "Vanta Bioscience Limited" and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Hyderabad on March 17, 2017. The corporate identification number is U74999TG2016PLC109280. The changes to the name of the Company were undertaken upon conversion of the Company from a private limited company to a public limited company. Major Events and Milestones 2016 - Incorporation of the Company 2017 - The Company concluded the purchase of the preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as ?Vanta Bioscience? (a toxicology division of Kemin Industries South Asia Private Limited) along with leasehold rights in 4.8 acres of land situated at Plot K2B, SIPCOT Industrial Estate, Gummidipundi, Chennai - 601201. -Company had successfully completed AAALACi recertification in July 2017. 2011 -Vanta Bioscience had received first full accreditation of Association for Assessment and Accreditation of Laboratory Animal Care international (AAALACi) in the year 2011 and renewed in the year 2014, 2017 and 2021 subsequently. 2012 -Vanta Bioscience has been certified under Bio-Rad External Quality Assurance Services (EQASr) programs since 2012, Under which specimen packs and documentation (reports); results are compared to other laboratories using the same methodologies, instruments, and reagents.

The Company was originally incorporated as a private limited company under the Companies Act, 2013 pursuant to a certificate of incorporation issued by the Registrar of Companies, Hyderabad dated April 29, 2016 with the name "Vanta Bioscience Private Limited`. The Company was converted into a public limited company pursuant to approval of the shareholders at an extraordinary general meeting held on February 13, 2017 and consequently, the name of the Company was changed to "Vanta Bioscience Limited" and a fresh certificate of incorporation consequent upon conversion to public limited company was issued by the Registrar of Companies, Hyderabad on March 17, 2017. The corporate identification number is U74999TG2016PLC109280. The changes to the name of the Company were undertaken upon conversion of the Company from a private limited company to a public limited company. Major Events and Milestones 2016 - Incorporation of the Company 2017 - The Company concluded the purchase of the preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as ?Vanta Bioscience? (a toxicology division of Kemin Industries South Asia Private Limited) along with leasehold rights in 4.8 acres of land situated at Plot K2B, SIPCOT Industrial Estate, Gummidipundi, Chennai - 601201. -Company had successfully completed AAALACi recertification in July 2017. 2011 -Vanta Bioscience had received first full accreditation of Association for Assessment and Accreditation of Laboratory Animal Care international (AAALACi) in the year 2011 and renewed in the year 2014, 2017 and 2021 subsequently. 2012 -Vanta Bioscience has been certified under Bio-Rad External Quality Assurance Services (EQASr) programs since 2012, Under which specimen packs and documentation (reports); results are compared to other laboratories using the same methodologies, instruments, and reagents.

Parent Organisation

Vanta Bioscience Ltd.

Founded

29/04/2016

Managing Director

Mr.Dopesh Raja Mulakala

NSE Symbol

FAQ